Furthermore, previous studies found that CCL19 is upregulated in inflamed islets in nonobese diabetic mice (Shan et al., 2014) and type 2 diabetes (Santopaolo et al., 2021), suggesting that CCL19 is widely upregulated in both type 1 and 2 diabetes. This evidence concerns the gene CCL19 and type 2 diabetes mellitus.